Thomas Fréour

Thomas Fréour

Auto-generated profile, based on publicly available information

Thomas Fréour

CHU Nantes, Nantes Université, Service de biologie et médecine de la reproduction , Nantes

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2021 in Nature
Verified
Journal Article
Open access
PDF file
HKHarunobu Kagawa
Harunobu Kagawa
AJAlok Javali
Alok Javali
HKHeidar Heidari Khoei
Heidar Heidari Khoei
TSTheresa Maria Sommer
Theresa Maria Sommer
GSGiovanni Sestini
Giovanni Sestini
NRNicolas Rivron
Nicolas Rivron
One week after fertilization, human embryos implant into the uterus. This event requires the embryo to form a blastocyst consisting of a sphere encircling a cavity lodging the embryo proper. Stem cells can form a blastocyst model that we called a blastoid1. Here we show that naive human pluripotent stem cells cultured in PXGL medium2and triply inhibited for the Hippo, TGF-β and ERK pathways efficiently (with more than 70% efficiency) form blastoids generating blastocyst-stage analogues of the three founding lineages (more than 97% trophectoderm, epiblast and primitive endoderm) according to the sequence and timing of blastocyst development. Blastoids spontaneously form the first axis, and we observe that the epiblast induces the local maturation of the polar trophectoderm, thereby endowing blastoids with the capacity to directionally attach to hormonally stimulated endometrial cells, as during implantation. Thus, we propose that such a human blastoid is a faithful, scalable and ethical model for investigating human implantation and development3,4.

4 March 2019 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
NSNathalie Sermondade
Nathalie Sermondade
SHStéphanie Huberlant
Stéphanie Huberlant
VBVanessa Bourhis-Lefebvre
Vanessa Bourhis-Lefebvre
EAElisangela Arbo
Elisangela Arbo
VGVanessa Gallot
Vanessa Gallot
TFThomas Fréour
Thomas Fréour
A worldwide increase in the prevalence of obesity has been observed in the past three decades, particularly in women of reproductive age. Female obesity has been clearly associated with impaired spontaneous fertility, as well as adverse pregnancy outcomes. Increasing evidence in the literature shows that obesity also contributes to adverse clinical outcomes following in vitro fertilization (IVF) procedures. However, the heterogeneity of the available studies in terms of populations, group definition and outcomes prevents drawing firm conclusions. A previous meta-analysis published in 2011 identified a marginal but significant negative effect of increased female body mass index (BMI) on IVF results, but numerous studies have been published since then, including large cohort studies from national registries, highlighting the need for an updated review and meta-analysis. Our systematic review and meta-analysis of the available literature aims to evaluate the association of female obesity with the probability of live birth following IVF. Subgroup analyses according to ovulatory status, oocyte origin, fresh or frozen-embryo transfer and cycle rank were performed. A systematic review was performed using the following key words: (‘obesity’, ‘body mass index’, ‘live birth’, ‘IVF’, ‘ICSI’). Searches were conducted in MEDLINE, EMBASE, Cochrane Library, Eudract and clinicaltrial.gov from 01 January 2007 to 30 November 2017. Study selection was based on title and Full texts of potentially relevant articles were retrieved and assessed for inclusion by two reviewers. Subsequently, quality was assessed using the Newcastle-Ottawa Quality Assessment Scales for patient selection, comparability and assessment of outcomes. Two independent reviewers carried out study selection and data extraction according to Cochrane methods. Random-effect meta-analysis was performed using Review Manager software on all data (overall analysis), followed by subgroup analyses. A total of 21 studies were included in the meta-analysis. A decreased probability of live birth following IVF was observed in obese (BMI ≥ 30 kg/m2) women when compared with normal weight (BMI 18.5–24.9 kg/m2) women: risk ratio (RR) (95% CI) 0.85 (0.82–0.87). Subgroups analyses demonstrated that prognosis was poorer when obesity was associated with polycystic ovary syndrome, while the oocyte origin (donor or non-donor) did not modify the overall interpretation. Our meta-analysis clearly demonstrates that female obesity negatively and significantly impacts live birth rates following IVF. Whether weight loss can reverse this deleterious effect through lifestyle modifications or bariatric surgery should be further evaluated.

1 September 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
DMDimitri Meistermann
Dimitri Meistermann
ABAlexandre Bruneau
Alexandre Bruneau
SLSophie Loubersac
Sophie Loubersac
ARArnaud Reignier
Arnaud Reignier
JFJulie Firmin
Julie Firmin
LDLaurent David
Laurent David

1 January 2008 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
TFThomas Freour
Thomas Freour
DMDamien Masson
Damien Masson
SMSophie Mirallie
Sophie Mirallie
MJMiguel Jean
Miguel Jean
KBKalyane Bach
Kalyane Bach
PBPaul Barriere
Paul Barriere

1 June 2013 in Fertility and Sterility
Verified
Journal Article
Closed access
TFThomas Fréour
Thomas Fréour
LDLionel Dessolle
Lionel Dessolle
JLJenna Lammers
Jenna Lammers
SLStéphanie Lattes
Stéphanie Lattes
PBPaul Barrière
Paul Barrière

1 July 2017 in European Journal of Cancer
Verified
Journal Article
Closed access
ADA. Dezellus
A. Dezellus
PBP. Barriere
P. Barriere
MCM. Campone
M. Campone
CLC. Lemanski
C. Lemanski
LVL. Vanlemmens
L. Vanlemmens
TFT. Freour
T. Freour